Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Quintiles Rx Market Monitor Provides Real-Time Rx Share Info On Internet

Executive Summary

Market share for Searle's Celebrex is "leveling off," while Merck's Vioxx is "poised to surpass" the older product, according to an NSAID market share analysis generated by Quintiles' new Rx Market Monitor web-based market research informatics product.

You may also be interested in...



Quintiles Draws Rx Data From Nine Pharmacy Chains After WebMD Settlement

Quintiles has secured rights to de-identified Rx data from nine pharmacy chains to help replace the healthcare claims data it will stop receiving from WebMD under the companies' settlement.

Quintiles Draws Rx Data From Nine Pharmacy Chains After WebMD Settlement

Quintiles has secured rights to de-identified Rx data from nine pharmacy chains to help replace the healthcare claims data it will stop receiving from WebMD under the companies' settlement.

CROs Counting On Biotech Stock Rise, Phase IV Trials To Drive New Business

Recently enriched biotechnology companies will help the contract research organization market recover from its slump in the coming year, PPD CEO Fred Eshelman, MD, told analysts during an April 20 conference call.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS035798

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel